COVID-19: a cause of recurrent Graves' hyperthyroidism?

被引：59

作者：

Jimenez-Blanco, S. ^{[1
]}

Pla-Peris, B. ^{[2
]}

Marazuela, M. ^{[1
]}

机构：

[1] Univ Hosp La Princesa, Dept Endocrinol & Nutr, Madrid, Spain

[2] Hosp Arnau Vilanova, Dept Endocrinol & Nutr, Valencia, Spain

来源：

JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION | 2021年 / 44卷 / 02期

关键词：

D O I：

10.1007/s40618-020-01440-0

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：387 / 388

页数：2

共 5 条

[1]

Barutta Federica, 2014, ENDOCRINE, V48, P730, DOI [10.1007/s12020-014-0437-1, DOI 10.1007/S12020-014-0437-1]

[2] The pathogenesis of thyroid autoimmune diseases: New T lymphocytes - Cytokines circuits beyond the Th1-Th2 paradigm [J].

Li, Qian ;

Wang, Bin ;

Mu, Kaida ;

Zhang, Jin-An .

JOURNAL OF CELLULAR PHYSIOLOGY, 2019, 234 (03) :2204-2216

[3] SARS-COV-2 as a trigger for autoimmune disease: report of two cases of Graves' disease after COVID-19 [J].

Mateu-Salat, M. ;

Urgell, E. ;

Chico, A. .

JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2020, 43 (10) :1527-1528

[4] The environment and autoimmune thyroid diseases [J].

Prummel, MF ;

Strieder, T ;

Wiersinga, WM .

EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2004, 150 (05) :605-618

[5] Increased serum concentrations of interleukin-6 (IL-6) and soluble IL-6 receptor in patients with Graves' disease [J].

Salvi, M ;

Girasole, G ;

Pedrazzoni, M ;

Passeri, M ;

Giuliani, N ;

Minelli, R ;

Braverman, LE ;

Roti, E .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1996, 81 (08) :2976-2979

← 1 →